Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Glasauer

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Biology : CB|February 9, 2013
ROSAndrea Glasauer, Navdeep S Chandel
Biochemical Pharmacology|August 1, 2014
Targeting antioxidants for cancer therapyAndrea Glasauer, Navdeep S Chandel
The Journal of Clinical Investigation|December 3, 2013
Targeting SOD1 reduces experimental non–small-cell lung cancerAndrea Glasauer, Laura A Sena, Lauren P Diebold, et al.
Plos One|August 6, 2016
Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell LinesIlya Kovalenko, Andrea Glasauer, Laura Schöckel, et al.
Cancer & Metabolism|October 27, 2015
Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growthLaura Schöckel, Andrea Glasauer, Farhan Basit, et al.
Science Signaling|February 7, 2013
Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle developmentRobert B Hamanaka, Andrea Glasauer, Paul Hoover, et al.
Elife|May 21, 2014
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesisWilliam W Wheaton, Samuel E Weinberg, Robert B Hamanaka, et al.
JAMA Cardiology|June 3, 2026
Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical TrialsKevin Bryan Lo, John W Ostrominski, Yasuhiro Hamatani, et al.
Journal of the American College of Cardiology|July 30, 2025
Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF TrialMuthiah Vaduganathan, Brian L Claggett, Jacob A Udell, et al.
JAMA Cardiology|March 28, 2026
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HFMisato Chimura, Kirsty McDowell, Pardeep S Jhund, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Biology : CB|February 9, 2013
ROSAndrea Glasauer, Navdeep S Chandel
Biochemical Pharmacology|August 1, 2014
Targeting antioxidants for cancer therapyAndrea Glasauer, Navdeep S Chandel
The Journal of Clinical Investigation|December 3, 2013
Targeting SOD1 reduces experimental non–small-cell lung cancerAndrea Glasauer, Laura A Sena, Lauren P Diebold, et al.
Plos One|August 6, 2016
Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell LinesIlya Kovalenko, Andrea Glasauer, Laura Schöckel, et al.
Cancer & Metabolism|October 27, 2015
Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growthLaura Schöckel, Andrea Glasauer, Farhan Basit, et al.
Science Signaling|February 7, 2013
Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle developmentRobert B Hamanaka, Andrea Glasauer, Paul Hoover, et al.
Elife|May 21, 2014
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesisWilliam W Wheaton, Samuel E Weinberg, Robert B Hamanaka, et al.
JAMA Cardiology|June 3, 2026
Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical TrialsKevin Bryan Lo, John W Ostrominski, Yasuhiro Hamatani, et al.
Journal of the American College of Cardiology|July 30, 2025
Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF TrialMuthiah Vaduganathan, Brian L Claggett, Jacob A Udell, et al.
JAMA Cardiology|March 28, 2026
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HFMisato Chimura, Kirsty McDowell, Pardeep S Jhund, et al.
Pageof 2